Core Viewpoint - Algenesis is pioneering the production of the world's first non-phosgene bio-based isocyanate, aiming to disrupt the polyurethane industry, which heavily relies on toxic phosgene, by offering sustainable and high-performance materials [1][4]. Group 1: Company Overview - Algenesis, founded in 2016, focuses on developing and commercializing bio-based, biodegradable polyurethane materials, with its core product line, Soleic®, containing 56-100% bio-based content [20]. - The company has received significant recognition, including the Polyurethane Innovation Award from the American Chemistry Council and a $6 million grant from the U.S. Department of Energy [4][20]. Group 2: Technology and Innovation - The breakthrough technology, Bio-Iso™, is a 100% plant-based, non-phosgene isocyanate that has entered pilot production, with current capacity at 1 kg/day and plans to scale to 10 kg/day [5][18]. - Algenesis emphasizes the importance of high-value applications in the polyurethane market, which spans various sectors including plastics, foams, and adhesives, to ensure competitiveness against petroleum-based alternatives [5][18]. Group 3: Market Strategy - Algenesis targets high-end markets in Europe, where consumers are willing to pay a premium for sustainable materials, and has partnered with distributors like Safic-Alcan to facilitate market entry [13][18]. - The company adopts a strategy of starting with premium brands willing to pay extra for innovative materials, allowing for gradual scaling and cost reduction [13][18]. Group 4: Supply Chain and Production - Algenesis employs a "short-long term combination" strategy for raw material sourcing, collaborating with P2 Science to lower costs and expand supply channels for bio-based intermediates [16][18]. - The company plans a phased capacity expansion from 1 kg/day to ton-scale production, aligning with market demand from major brands like Adidas and Target [17][18]. Group 5: Insights for the Bio-based Industry - Algenesis's journey highlights the need for bio-based materials to focus on high-value segments and to align commercialization efforts with resource constraints [19]. - The company’s experience underscores the importance of early supply chain planning and partnerships to facilitate scaling from niche to mainstream markets [19].

Group 1 - Ecovia Bio has completed a Series B financing round led by Pointe Angels, with funds aimed at expanding its production facility in Livonia to significantly increase the capacity of γ-PGA biodegradable materials to meet the growing global demand for biodegradable superabsorbent polymers [2][4] - Traditional petroleum-based superabsorbent polymers (SAPs) used in consumer products like diapers and cosmetics can persist in landfills for hundreds of years and break down into harmful microplastics, raising serious health concerns as microplastics have been detected in human blood, lungs, and placental tissue [2] - γ-PGA, a natural anionic polymer synthesized by microorganisms, offers excellent biocompatibility, complete biodegradability, and non-toxicity, making it a functional alternative to traditional petrochemical polymers in various sectors including cosmetics and personal care [3] Group 2 - The expansion plan supported by the recent financing will upgrade the Livonia production facility, which is the first commercial production base for γ-PGA in the U.S., expected to operate at full capacity by 2028, significantly enhancing the global supply of γ-PGA products [4] - The company has initiated evaluations for additional production facilities to address the sustained market demand post-2028, ensuring supply chain security for global partners [4]

Core Insights - The article emphasizes the growth and transformation of the bio-based and biomanufacturing industry in 2025, aligning with global green transition trends and China's "dual carbon" strategy [2][3] - The industry is moving from a technology exploration phase to a critical stage of industrialization and marketization, with bio-based materials expected to penetrate various sectors [2] Group 1: Events and Achievements - The 10th Bio-based Conference and Exhibition was held in Shanghai from May 25-27, gathering over 1,000 experts and industry leaders, with more than 100 leaders sharing insights [4][6] - The DT New Leaf Award recognized over 100 products in the bio-based industry, with 28 products winning awards across various categories [7] - The official launch of the bio-based and biomanufacturing service platform attracted over 500 domestic and international companies to its "new product library" [2] Group 2: Future Outlook - The bio-based and biomanufacturing industry is expected to achieve a leap from "substitution" to "leadership" in various fields, indicating a significant shift in market dynamics [2] - The company aims to continue fostering collaboration among industry peers to accelerate technology transfer and contribute to a green, low-carbon circular economy [3] Group 3: Upcoming Events - The 11th Bio-based Conference and Exhibition is scheduled for May 20-22, 2026, featuring 11 thematic forums and 1,000 new product displays [30] - The 5th Synthetic Biology and Green Biomanufacturing Conference will take place in August 2026, focusing on innovative applications and AI in biomanufacturing [30] - The 6th Non-food Biomass High-Value Utilization Forum is planned for November 2026, addressing sustainable aviation fuel and carbon utilization [30]

Core Insights - The article emphasizes the growth and transformation of the bio-based and bio-manufacturing industry in 2025, aligning with global green transition trends and China's "dual carbon" strategy [2][3] - The industry has moved from a technology exploration phase to a critical stage of industrialization and marketization, with bio-based materials expected to penetrate various sectors [2] Summary by Sections Part 1: Bio-based 2025 - The 10th Bio-based Conference and Exhibition was held in Shanghai, gathering over 1,000 experts and industry leaders, with more than 100 industry leaders sharing insights [4] - The event featured over 20 specialized sessions and discussions on international trends, technology, and applications in the bio-based industry [4][6] - The DT New Leaf Award recognized over 70 products, with 28 winners across various categories, highlighting innovation in the sector [7] Part 2: SynBioCon 2025 - The 4th Synthetic Biology and Green Bio-manufacturing Conference took place in Ningbo, attracting over 400 participants, including 60 experts [9] - The conference included 40 presentations and discussions across four major themes, focusing on macro trends in bio-manufacturing and AI applications [9] Part 3: NFUCon 2025 - The 5th Non-food Biomass High-Value Utilization Forum was held in Hangzhou, with over 400 industry experts discussing economic feasibility and sustainable resource utilization [12] - The forum featured discussions on non-food biomass chemicals, materials, and energy, along with three special activities [12] Part 4: GCMF 2025 - The 4th Green Composite Materials Forum was successfully held, focusing on fiber and resin technologies and promoting collaboration between academia and industry [20] - The forum aimed to drive technological breakthroughs in green composite materials [20] Additional Activities - The 3rd Polymer Recycling Conference was held in Ningbo, focusing on policies, recycling technologies, and high-value utilization of waste polymers, with nearly 300 industry representatives attending [24] - The company aims to facilitate technology transfer and industry collaboration through various events and platforms [26]

Core Viewpoint - Spiber, a Japanese unicorn company specializing in spider silk protein fibers, is advancing its business through strategic partnerships and innovative material development, aiming for significant growth in the sustainable fashion and personal care sectors [1][4][5]. Group 1: Business Developments - Spiber has signed a business support agreement with Maya Kawana, who will begin her work in the first half of 2026, aiming to leverage synergies for further development and value creation [2]. - The company raised 10 billion yen (approximately 65 million USD) in its ninth funding round, marking a significant milestone in its financial growth [4]. Group 2: Product Innovation - Spiber has developed Brewed Protein™, a synthetic spider silk material that boasts four times the toughness of steel at the same size, comparable elasticity to nylon, and excellent heat resistance up to 300°C [6]. - The Brewed Protein™ material is biodegradable in natural soil and seawater, potentially enabling a closed-loop supply chain for sustainable production [6]. Group 3: Production Capacity - As of 2024, Spiber's annual production capacity is between 200-300 tons, making it the only industrial-scale protein fiber that meets ISO standards, with plans to expand production to 1,000 tons in the coming years [7]. Group 4: Market Presence - Spiber has established a growing sales network, collaborating with 20 brands and launching 86 products, including partnerships with renowned companies like North Face Japan and Goldwin [9]. - The collaboration with Goldwin has reached its tenth year, focusing on high-performance tech apparel made entirely from Brewed Protein™ [10][11]. Group 5: Future Directions - The company is focusing on reducing dyeing process pollution and utilizing renewable agricultural by-products as raw materials for future product lines [14].

As filed with the Securities and Exchange Commission on September 8, 2025. Registration No. 333-285692 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 AMENDMENT NO. 4 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REGENTIS BIOMATERIALS LTD. (Exact name of registrant as specified in its charter) | State of Israel | 2834 | Not Applicable | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or orga ...

As filed with the Securities and Exchange Commission on September 19, 2024 Registration No. 333-282014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BOLT PROJECTS HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 2860 86-1256660 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identif ...

As filed with the Securities and Exchange Commission on September 9, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BOLT PROJECTS HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Delaware | | --- | (State or other jurisdiction of incorporation or organization) Delaware 2860 86-1256660 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificati ...